Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine, ketamine, and Altadin for prevention of postoperative sore throat after endotracheal intubation
IRCT20101211005362N28Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of lidocaine and ketamine in Post-extubation sore throat (POST) and cough (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Frequency of sore throat after surgery, Frequency of itchy and 5 more. Started Jan 2022; status: completed.
02
Drugs
lidocaineketamine
03
Conditions
Post-extubation sore throat (POST)cough
Beyond the preview
Go deeper on IRCT20101211005362N28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101211005362N28.